Andrea De Luca mainly investigates Internal medicine, Immunology, Viral load, Genetics and Acquired immunodeficiency syndrome. Her work carried out in the field of Internal medicine brings together such families of science as Gastroenterology, Sida and Surgery. Her biological study spans a wide range of topics, including Cohort study and Ritonavir.
Her Immunology research incorporates themes from Nevirapine, Epidemiology and Incidence. Her research in Viral load intersects with topics in Chemotherapy, Viral disease, Regimen, Drug resistance and Drug. In general Genetics study, her work on Genome-wide association study, Allele and Gene often relates to the realm of Transmission, thereby connecting several areas of interest.
Her scientific interests lie mostly in Internal medicine, Immunology, Virology, Viral load and Regimen. Her work deals with themes such as Gastroenterology, Oncology and Ritonavir, which intersect with Internal medicine. Her Immunology research is multidisciplinary, incorporating elements of Acquired immunodeficiency syndrome, Incidence and Confidence interval.
Her studies in Virology integrate themes in fields like Protease inhibitor, Reverse transcriptase and Genotype. Andrea De Luca combines subjects such as Surgery, Drug resistance and Drug with her study of Viral load. As a member of one scientific family, Andrea De Luca mostly works in the field of Regimen, focusing on Lamivudine and, on occasion, Atazanavir.
Her scientific interests lie mostly in Internal medicine, Virology, Regimen, Viral load and Lamivudine. Her Internal medicine study incorporates themes from Gastroenterology, Oncology and Ritonavir. Her research in Gastroenterology tackles topics such as Immunology which are related to areas like Pneumococcal conjugate vaccine and Group A.
Her biological study deals with issues like Raltegravir, which deal with fields such as Integrase inhibitor. Her study looks at the intersection of Regimen and topics like Dolutegravir with Tolerability and Public health. Andrea De Luca has included themes like Efficacy, Survival analysis and Drug resistance in her Viral load study.
Her main research concerns Internal medicine, Ritonavir, Lamivudine, Regimen and Gastroenterology. Her Internal medicine research incorporates elements of Darunavir and Viral load. Viral load is the subject of her research, which falls under Immunology.
In her research on the topic of Immunology, Virology is strongly related with Hiv infected. Her study on Ritonavir also encompasses disciplines like
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1
Jacques Fellay;Kevin V. Shianna;Dongliang Ge;Sara Colombo.
Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management
Annemarie M. J. Wensing;David A. van de Vijver;Gioacchino Angarano;Birgitta Åsjö.
The Journal of Infectious Diseases (2005)
Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study
Linda Wittkop;Huldrych F Günthard;Frank de Wolf;David Dunn.
Lancet Infectious Diseases (2011)
Common genetic variation and the control of HIV-1 in humans.
Jacques Fellay;Dongliang Ge;Kevin V. Shianna;Sara Colombo.
PLOS Genetics (2009)
Competing risks and prognostic stages of cirrhosis: A 25-year inception cohort study of 494 patients
G. D'Amico;L. Pasta;A. Morabito;M. D'Amico.
Alimentary Pharmacology & Therapeutics (2014)
Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects.
Andrea De Luca;Roberto Bugarini;Alessandro Cozzi Lepri;Massimo Puoti.
JAMA Internal Medicine (2002)
Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA).
Antonella Cingolani;Andrea Antinori;Maria Gabriella Rizzo;Rita Murri.
Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy.
Andrea Antinori;Antonella Cingolani;Lucia Alba;Adriana Ammassari.
Patient-reported nonadherence to HAART is related to protease inhibitor levels.
Rita Murri;Adriana Ammassari;Keith Gallicano;Andrea De Luca.
Journal of Acquired Immune Deficiency Syndromes (2000)
Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA).
Andrea Antinori;Antonella Cingolani;Patrizia Lorenzini;Maria Letizia Giancola.
Journal of NeuroVirology (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: